AAHP’s Work in Washington: A Retrospective Heading into Our Centennial
By Pete Evich, Vice President, Van Scoyoc Associates It was 12 years ago that the American Association of Homeopathic Pharmacists (AAHP) first embarked upon a federal relations program. While…
Read MoreAAHP Updates Rep. Curtis on Homeopathic Industry Issues
On Sept. 16, 2022, AAHP once again sat down with U.S. Congressman John Curtis (R-Utah-3rd district) to brief him on the homeopathic industry and AAHP’s current work with the U.S.…
Read MoreNewly Revised FDA Inspection Guidance Document
By Eric Foxman, AAHP Secretary, Pharm. (Ret.) The U.S. Food and Drug Administration released a revised Inspection Guidance for its staff. While the overall contents are not new, it is…
Read MorePharmacy Spotlight: Anthony Qaiyum of Merz Apothecary
What are consumers looking for from homeopathy today? As manufacturers, how can we best serve them? An excellent way to get a pulse on our consumers is to look to…
Read MoreCreating Awareness for and Protecting Homeopathic Products
By Mark Land, AAHP President People imagine “Public Affairs” as meaning fancy-suited lobbyists manipulating legislators in ways that don’t benefit the public. This oversimplifies the process and is demeaning to…
Read MoreGrocer H-E-B Cultivates the Natural Product Shopper; AAHP Gives Top Honor
H-E-B provides customers with more than just a great place to shop. The retailer promotes local products made in Texas, frequently donates to many community causes, and invests in various…
Read MoreThe AAHP Industry Reception: An Evening of Extraordinary Networking
On Sept. 29, AAHP celebrated the industry with its fourth annual Industry Reception and the presentation of the Integrative Medicine Retailer Award. Designed to connect and support retailers who champion…
Read MoreRoyal S. Copeland: We Know The Name – But Do We Know The Man?
By Eric Foxman, AAHP Secretary, Pharm. (Ret.) The homeopathic community is likely familiar with the name of the framer of the U.S. Food, Drug and Cosmetic Act, and the value…
Read MoreDevelopments on Capitol Hill of Interest for AAHP Members
Senate Leadership of Key Committees Overseeing FDA/FTC Will See Changes in Next Congress Leaders of Influential House Committee to Remain but Role Reversal Predicted By Pete Evich, Vice President, Van…
Read MoreFDA Warning Letters for Skin Tag and Mole Removal OTCs
By Alvin Lorman, AAHP Counsel The Food and Drug Administration (FDA) has reminded two OTC drug manufacturers that mole and skin tag removal are prescription-only indications. The agency issued Warning…
Read More